Jun 08, 2022 / 01:30PM GMT
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity Analyst
All right. Good morning, everyone. Welcome to another great session here at the Jefferies 2022 in-person Global Healthcare Conference. It's great to see so many faces and friends.
Up here on the stage with us we have Arvind Sood, Vice President of Investor Relations, who everybody knows; as well as Murdo Gordon, EVP of Global Commercial Operations. He's running everything behind the scenes in terms of commercial operations and sales. We obviously have a lot to talk about. We'll go right into it.
Questions and Answers:
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity AnalystFirst, I guess, just maybe big picture for Arvind and Murdo about 2022. We're sort of coming out of COVID. You have guidance. I guess as an analyst, I was sort of surprised we didn't raise guidance. But without getting the nuances of 2022, maybe just talk about your outlook for 2022, and how you guys feel about numbers and things as we're coming out of COVID and how are things tracking
Trustpilot
